Mohsen Rashidi
- Cancer Research top 5%
- MicroRNA in disease regulation 22
- Cancer-related molecular mechanisms research 22
- Molecular Biology top 10%
- Circular RNAs in diseases 18
- RNA modifications and cancer 6
- RNA Interference and Gene Delivery 5
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 7
- Oncology top 10%
- Toxicology top 5%
-
- Plant chemical constituents analysis 5
-
- Nanoplatforms for cancer theranostics 5
- Co-authors
- Mehrdad HashemiAfshin TaheriazamMaliheh EntezariShokooh SalimimoghadamKiavash HushmandiMarjan GhorbaniSepideh MirzaeiMatin Chehelgerdi
In The Last Decade
Mohsen Rashidi
91 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Cancer Research 488
- Molecular Biology 996
- Biomaterials 174
- Oncology 320
- Toxicology 39
Countries citing papers authored by Mohsen Rashidi
This map shows the geographic impact of Mohsen Rashidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohsen Rashidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohsen Rashidi more than expected).
Fields of papers citing papers by Mohsen Rashidi
This network shows the impact of papers produced by Mohsen Rashidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohsen Rashidi. The network helps show where Mohsen Rashidi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mohsen Rashidi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapybreakdown → | 2024 | 113 |
| 2 | 2024 | 3 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 13 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 15 | |
| 13 | 2023 | 35 | |
| 14 | 2023 | 0 | |
| 15 | 2022 | 40 | |
| 16 | 2021 | 15 | |
| 17 | 2021 | 6 | |
| 18 | 2020 | 16 | |
| 19 | 2020 | 50 | |
| 20 | 2018 | 35 |
About Mohsen Rashidi
Mohsen Rashidi is a scholar working on Cancer Research, Toxicology and Applied Microbiology and Biotechnology, having authored 96 papers that have together received 1.9k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (22 papers), Cancer-related molecular mechanisms research (22 papers), Circular RNAs in diseases (18 papers), Nanoparticle-Based Drug Delivery (7 papers), RNA modifications and cancer (6 papers), RNA Interference and Gene Delivery (5 papers), Plant chemical constituents analysis (5 papers) and Nanoplatforms for cancer theranostics (5 papers). The work is most often cited by research in Cancer Research (488 citations), Molecular Biology (996 citations) and Biomaterials (174 citations). Mohsen Rashidi has collaborated with scholars based in Iran, Canada and China. Frequent co-authors include Mehrdad Hashemi, Afshin Taheriazam, Maliheh Entezari, Shokooh Salimimoghadam, Kiavash Hushmandi, Marjan Ghorbani, Sepideh Mirzaei, Matin Chehelgerdi, Mohammad Chehelgerdi and Noushin Nabavi. Their work appears in journals such as Biomedicine & Pharmacotherapy, Hormone Molecular Biology and Clinical Investigation, Pharmacological Research, Translational Oncology and Non-coding RNA Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.